Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 107
Filtrer
1.
Braz J Med Biol Res ; 56: e12921, 2023.
Article de Anglais | MEDLINE | ID: mdl-38126617

RÉSUMÉ

Intratumoral similarities and differences between large-cell neuroendocrine carcinomas (LCNECs) and small-cell lung carcinomas (SCLCs) are determined partially by the Notch signaling pathway, which controls the switch from neuroendocrine to slight/non-neuroendocrine cell fate. LCNECs are divided into two subgroups according to genomic alterations: type I LCNECs exhibit a neuroendocrine profile characterized by achaete-scute homolog 1 (ASCL1)high/delta-like protein 3 (DLL3)high/NOTCHlow and type II LCNECs show the pattern ASCL1low/DLL3low/NOTCHhigh. Here, we used immunohistochemistry, transmission electron microscopy, and digital analysis to examine the role of the Notch ligand DLL3 as an immunomarker of the neuroendocrine state and ASCL1 as a regulator of cell-cell interactions in SCLCs and LCNECs. High DLL3 and ASCL1 expression was associated with atypical submicroscopic characteristics involving nuclear size, chromatin arrangement, Golgi apparatus, and endoplasmic reticulum, and was characteristic of type I LCNECs with similarity to SCLCs, whereas low DLL3 and ASCL1 expression was found in both SCLCs and type II LCNECs. In patients diagnosed at an early stage who did not have metastasis and who underwent chemotherapy, DLL3high and ASCL1high SCLCs and type I LCNECs were associated with a better prognosis and a lower risk of death. The present findings suggested that DLL3/ASCL1 are potential therapeutic targets and prognostic indicators in patients with SCLCs or LCNECs.


Sujet(s)
Carcinome neuroendocrine , Tumeurs du poumon , Humains , Tumeurs du poumon/génétique , Carcinome neuroendocrine/génétique , Carcinome neuroendocrine/anatomopathologie , Immunohistochimie , Protéines oncogènes , Poumon/anatomopathologie , Facteurs de transcription à motif basique hélice-boucle-hélice/métabolisme , Protéines membranaires/métabolisme , Protéines et peptides de signalisation intracellulaire
2.
Braz J Med Biol Res ; 56: e12922, 2023.
Article de Anglais | MEDLINE | ID: mdl-37970922

RÉSUMÉ

Nuclear proliferation marker MIB-1 (Ki-67) immunohistochemistry (IHC) is used to examine tumor cell proliferation. However, the diagnostic or prognostic value of the Ki-67 nuclear staining intensity and location, defined as nuclear gradient (NG), has not been assessed. This study examined the potential association between Ki-67 NG and cell cycle phases and its effect on the prognosis of pulmonary typical carcinoid (PTC) tumors. We propose a method for classifying the NG of Ki-67 during the cell cycle and compare the results between PTC, pulmonary adenocarcinoma (PAD), and breast ductal carcinoma (BDC). A literature review and objective analysis of IHC-stained paraffin sections were used to determine the Ki-67 labeling index and composed a stratification of the NG into NG1, NG2, and NG3/4 categories. A semi-automated image analysis protocol was established to determine the Ki-67 NG in PTC, PAD, and BDC. High intraobserver consistency and moderate interobserver agreement were achieved in the determination of Ki-67 NG in tumor specimens. NG1 and NG2 were lower in PTC than in PAD and BDC. Cox multivariate analysis of PTC after adjusting for age and number of metastatic lymph nodes showed that Ki-67 NG1 and NG2 significantly predicted clinical outcomes. The semi-automated method for quantification of Ki-67 nuclear immunostaining proposed in this study could become a valuable diagnostic and prognostic tool in PTC.


Sujet(s)
Antigène KI-67 , Immunohistochimie , Antigène KI-67/métabolisme
4.
Front Oncol ; 13: 1104630, 2023.
Article de Anglais | MEDLINE | ID: mdl-37251932

RÉSUMÉ

Background: The treatment landscape for ovarian cancer has changed in recent years with the introduction of targeted therapies to treat patients with advanced disease. We investigated patient demographic and clinical factors associated with use of targeted therapies as a part of the first-line treatment for ovarian cancer. Methods: This study included patients diagnosed with stage I-IV ovarian cancer between 2012 and 2019 from the National Cancer Database. Information on demographic and clinical characteristics were collected and described using frequency and percent across receipt of targeted therapy. Logistic regression was used to compute the odds ratios (ORs) and 95% confidence intervals (CI) associating patient demographic and clinical factors with receipt of targeted therapy. Results: Among 99,286 ovarian cancer patients (mean age 62 years), 4.1% received targeted therapy. The rate of targeted therapy receipt across racial and ethnic groups over the study period was fairly similar; however, non-Hispanic Black women were less likely to receive targeted therapy than their non-Hispanic White counterparts (OR=0.87, 95% CI: 0.76-1.00). Patients who received neoadjuvant chemotherapy were more likely to receive targeted therapy than those who received adjuvant chemotherapy (OR=1.26; 95% CI: 1.15-1.38). Moreover, among patients who received targeted therapy, 28% received neoadjuvant targeted therapy, with non-Hispanic Black women being most likely to receive neoadjuvant targeted therapy (34%) compared with other racial and ethnic groups. Conclusions: We observed differences in receipt of targeted therapy by factors such as age at diagnosis, stage, and comorbidities present at diagnosis, as well as factors related to healthcare access-including neighborhood education level and health insurance status. Approximately 28% of patients received targeted therapy in the neoadjuvant setting, which could negatively impact treatment outcomes and survival due to the increased risk of complications associated with targeted therapies that may delay or prevent surgery. These results warrant further evaluation in a cohort of patients with more comprehensive treatment information.

5.
Braz J Med Biol Res ; 56: e12488, 2023.
Article de Anglais | MEDLINE | ID: mdl-37042869

RÉSUMÉ

TP53 mutations are frequent in non-small cell lung cancer (NSCLC) and have been associated with poor outcome. The prognostic and predictive relevance of EGFR/TP53 co-mutations in NSCLC is controversial. We analyzed lung tissue specimens from 70 patients with NSCLC using next-generation sequencing to determine EGFR and TP53 status and the association between these status with baseline patient and tumor characteristics, adjuvant treatments, relapse, and progression-free (PFS) and overall survival (OS) after surgical resection. We found the EGFR mutation in 32.9% of patients (20% classical mutations and 12.9% uncommon mutations). TP53 missense mutations occurred in 25.7% and TP53/EGFR co-mutations occurred in 43.5% of patients. Stage after surgical resection was significantly associated with OS (P=0.028). We identified an association between progression-free survival and poor outcome in patients with distant metastases (P=0.007). We found a marginally significant difference in OS between genders (P=0.057) and between mutant and wild type TP53 (P=0.079). In univariate analysis, distant metastases (P=0.027), pathological stage (IIIA-IIIB vs I-II; P=0.028), and TP53 status (borderline significance between wild type and mutant; P=0.079) influenced OS. In multivariable analysis, a significant model for high risk of death and poor OS (P=0.029) selected patients in stage IIIA-IIIB, with relapse and distant metastases, non-responsive to platin-based chemotherapy and erlotinib, with tumors harboring EGFR uncommon mutations, with TP53 mutant, and with EGFR/TP53 co-mutations. Our study suggested that TP53 mutation tends to confer poor survival and a potentially negative predictive effect associated with a non-response to platinum-based chemotherapy and erlotinib in early-stage resected EGFR-mutated NSCLC.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Humains , Mâle , Femelle , Carcinome pulmonaire non à petites cellules/génétique , Carcinome pulmonaire non à petites cellules/chirurgie , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Tumeurs du poumon/génétique , Tumeurs du poumon/chirurgie , Tumeurs du poumon/traitement médicamenteux , Chlorhydrate d'erlotinib/usage thérapeutique , Brésil , Stadification tumorale , Récidive tumorale locale/anatomopathologie , Mutation , Récepteurs ErbB/génétique , Récepteurs ErbB/usage thérapeutique , Inhibiteurs de protéines kinases/usage thérapeutique , Protéine p53 suppresseur de tumeur/génétique
6.
Braz J Med Biol Res ; 55: e12409, 2023.
Article de Anglais | MEDLINE | ID: mdl-36629526

RÉSUMÉ

The common epidermal growth factor receptor (EGFR) mutations, such as the L858R point mutation in exon 21 and the in-frame deletional mutation in exon 19, have been definitively associated with response to EGFR-tyrosine kinase inhibitors (EGFR-TKI). However, the clinical outcome and response to treatment for many other rarer mutations are still unclear. In this study, we report the results of Brazilian patients in stage IB-IIIA non-small cell lung cancer (NSCLC) following complete resection with minimal residual disease and EGFR mutations treated with adjuvant chemotherapy and/or EGFR-TKIs. The frequency of EGFR mutations was investigated in 70 cases of early stage NSCLC. Mutations in exons 18 and 20, uncommon mutations in exons 19 and 21, as well as in exons 3, 7, 14, 16, 22, 27, and 28, and/or the presence of different mutations in a single tumor (complex mutations) are considered rare. EGFR mutations were detected in 23 tumors (32.9%). Fourteen cases carried rare mutations and were treated with platinum-based chemotherapy and two cases were treated with erlotinib. The clinical outcome is described case by case with references to the literature. Notably, we found two rare EGFR mutations and one of them with an unknown response to chemotherapy and/or EGFR-TKIs. We have provided complementary information concerning the clinical outcome and treatment of patients with early stage NSCLC for several rare EGFR mutations not previously or only rarely reported. Description of cases harboring rare mutations can support the decision-making process in this subset of patients.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Humains , Carcinome pulmonaire non à petites cellules/génétique , Carcinome pulmonaire non à petites cellules/traitement médicamenteux , Tumeurs du poumon/traitement médicamenteux , Tumeurs du poumon/génétique , Tumeurs du poumon/anatomopathologie , Brésil , Inhibiteurs de protéines kinases/usage thérapeutique , Mutation/génétique , Récepteurs ErbB/génétique , Récepteurs ErbB/usage thérapeutique , Résultat thérapeutique , Études rétrospectives
7.
Eur Ann Allergy Clin Immunol ; 55(2): 68-77, 2023 03.
Article de Anglais | MEDLINE | ID: mdl-35029100

RÉSUMÉ

Summary: Background.In the diagnostic work up of allergy, determining allergen component-specific immunoglobulin E (IgE) is important for diagnosis, prognosis and choice of treatment. The purpose of this study was to evaluate the performance of the immunoblotting assay (Euroline) in detection of IgE antibodies against timothy grass and birch pollen allergen components compared to fluorescent enzyme assay (ImmunoCAP, Phadia 250). Methods. A total of 128 serum samples from patients allergic to timothy grass and birch pollen were analysed. The levels of IgE antibodies to timothy grass and birch pollen were measured using Euroline DPA-Dx pollen 1 and ImmunoCAP assay. The two methods were then compared on binary (positive vs negative), semi-quantitative (IgE classes) and quantitative (concentration) levels. The two methods were also compared to results from skin prick testing. Results. The Euroline method showed a positive percentage agreement of 93% and negative percentage agreement of 94% with an overall accuracy of 94% when compared to ImmunoCAP. Kappa analysis showed moderate strength of agreement between the methods in determining IgE classes for 7/11 components tested. All components showed a positive correlation when analysed using Spearman's rank correlation. Conclusions. Overall, we found that there is good correlation between the Euroline and ImmunoCAP methods in measuring IgE sensitization.


Sujet(s)
Allergènes , Hypersensibilité , Humains , Betula , Poaceae , Hypersensibilité/diagnostic , Immunotransfert , Phleum , Immunoglobuline E
8.
Cancer Epidemiol Biomarkers Prev ; 32(2): 175-182, 2023 02 06.
Article de Anglais | MEDLINE | ID: mdl-36409506

RÉSUMÉ

BACKGROUND: We investigated racial and ethnic disparities in treatment sequence [i.e., neoadjuvant chemotherapy (NACT) plus interval debulking surgery (IDS) versus primary debulking surgery (PDS) plus adjuvant chemotherapy] among patients with ovarian cancer and its contribution to disparities in mortality. METHODS: Study included 37,566 women ages ≥18 years, diagnosed with stage III/IV ovarian cancer from the National Cancer Database (2004-2017). Logistic regression was used to compute ORs and 95% confidence intervals (CI) for racial and ethnic disparities in treatment sequence. Cox proportional hazards regression was used to estimate HRs and 95% CI for racial and ethnic disparities in all-cause mortality. RESULTS: Non-Hispanic Black (NHB) and Asian women were more likely to receive NACT plus IDS relative to PDS plus adjuvant chemotherapy than non-Hispanic White (NHW) women (OR: 1.12; 95% CI: 1.02-1.22 and OR: 1.12; 95% CI: 0.99-1.28, respectively). Compared with NHW women, NHB women had increased hazard of all-cause mortality (HR: 1.14; 95% CI: 1.09-1.20), whereas Asian and Hispanic women had a lower hazard of all-cause mortality (HR: 0.81; 95% CI: 0.74-0.88 and HR: 0.83; 95% CI: 0.77-0.88, respectively), which did not change after accounting for treatment sequence. CONCLUSIONS: NHB women were more likely to receive NACT plus IDS and experience a higher all-cause mortality rates than NHW women. IMPACT: Differences in treatment sequence did not explain racial disparities in all-cause mortality. Further evaluation of racial and ethnic differences in treatment and survival in a cohort of patients with detailed treatment information is warranted.


Sujet(s)
Inégalités en matière de santé , Disparités d'accès aux soins , Traitement néoadjuvant , Tumeurs de l'ovaire , Adolescent , Femelle , Humains , Carcinome épithélial de l'ovaire , Traitement médicamenteux adjuvant , Hispanique ou Latino , Tumeurs de l'ovaire/traitement médicamenteux , Tumeurs de l'ovaire/chirurgie ,
9.
J Immunother ; 46(1): 14-21, 2023 01 01.
Article de Anglais | MEDLINE | ID: mdl-36256124

RÉSUMÉ

Immunotherapy has been approved for stage III non-small cell lung cancer (NSCLC) as consolidation therapy after chemoradiation in patients whose disease does not progress after chemoradiation. However, many patients do not receive chemoradiation due to either the drugs' side effects or poor performance status. This study's objective is to investigate the association of immunotherapy combined with chemotherapy or Radiotherapy (RT) with the overall survival (OS) of stage III NSCLC patients who do not receive chemoradiation. Patients with stage III NSCLC who received either chemotherapy or RT with or without immunotherapy were identified from NCDB. The Cox proportional hazard regression analysis was implied to assess the effect of immunotherapy on survival after adjusting the model for age at diagnosis, race, sex, education, treatment facility type, insurance status, comorbidity score, histology year of diagnosis, and treatment types, such as chemotherapy and radiation therapy. The final analysis included 32,328 patients, among whom 3,205 (9.9%) received immunotherapy. In the multivariable analysis adjusted for all the factors previously mentioned, immunotherapy was associated with significantly improved OS (HR: 0.76, CI: 0.71-0.81) compared with no immunotherapy. Treatment with chemotherapy plus immunotherapy was significantly associated with improved OS (HR: 0.83, CI: 0.77-0.90) compared with chemotherapy without immunotherapy. Further, RT plus immunotherapy was associated with significantly improved OS (HR: 0.62, CI: 0.54-0.70) compared with RT alone. In this comprehensive analysis, the addition of immunotherapy to chemotherapy or radiotherapy was associated with improved OS compared with chemotherapy or radiation therapy without immunotherapy in stage III NSCLC patients.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Humains , Carcinome pulmonaire non à petites cellules/thérapie , Tumeurs du poumon/thérapie
10.
Chemosphere ; 306: 135580, 2022 Nov.
Article de Anglais | MEDLINE | ID: mdl-35810864

RÉSUMÉ

The presence of 1,4 dioxane in wastewater is associated with severe health and environmental issues. The removal of this toxic contaminant from the industrial effluents prior to final disposal is necessary. The study comprehensively evaluates the performance of sequential batch membrane bioreactor (MBR) for treating wastewater laden with 1,4 dioxane. Acetate was supplemented to the wastewater feed as an electron donor for enhancing and stimulating the microbial growing activities towards the degradation of 1,4 dioxane. The removal efficiency of 1,4 dioxane was maximized to 87.5 ± 6.8% using an acetate to dioxane (A/D) ratio of 4.0, which was substantially dropped to 31.06 ± 3.7% without acetate addition. Ethylene glycol, glyoxylic acid, glycolic acid, and oxalic acid were the main metabolites of 1,4 dioxane biodegradation using mixed culture bacteria. The 1,4 dioxane degrading bacteria, particularly the genus of Acinetobacter, were promoted to 92% at the A/D ratio of 4.0. This condition encouraged as well the increase of the main 1,4 dioxane degraders, i.e., Xanthomonadales (12.5%) and Pseudomonadales (9.1%). However, 50% of the Sphingobacteriales and 82.5% of Planctomycetes were reduced due to the inhibition effect of the 1,4 dioxane contaminate. Similarly, the relative abundance of Firmicutes, Verrucomicrobia, Chlamydiae, Actinobacteria, Chloroflexi, and Nitrospirae was reduced in the MBR at the A/D ratio of 4.0. The results derived from the microbial analysis and metabolites detection at different A/D ratios indicated that acetate supplementation (as an electron donor) maintained an essential role in encouraging the microorganisms to produce the monooxygenase enzymes responsible for the biodegradation process. Economic feasibility of such a MBR system showed that for a designed flow rate of 30 m3∙d-1, the payback period from reusing the treated wastewater would reach 6.6 yr. The results strongly recommend the utilization of mixed culture bacteria growing on acetate for removing 1,4 dioxane from the wastewater industry, achieving dual environmental and economic benefits.


Sujet(s)
Électrons , Eaux usées , Bactéries/métabolisme , Dépollution biologique de l'environnement , Bioréacteurs , Dioxanes/métabolisme
11.
Plants (Basel) ; 11(9)2022 Apr 28.
Article de Anglais | MEDLINE | ID: mdl-35567188

RÉSUMÉ

Developing high-yielding maize hybrids is essential under the fast-growing global population and abrupt global climate change. Planting density is one of the imperative components for enhancing maize productivity. This study assessed newly developed maize hybrids under three planting densities on two sowing dates. The evaluated hybrids were 40 maize genotypes comprised of 36 F1-developed hybrids and 4 commercial high-yielding check hybrids. The developed hybrids were generated from selected maize inbred lines according to their adaptive traits to high planting density, such as prolificacy, erect leaves, short plants, early silking, anthesis-silking interval, and small tassel size. The applied planting densities were high, intermediate, and low, with 95,000, 75,000, and 55,000 plants/ha, respectively, under timely and late sowing. The high planting density displayed the uppermost grain yield compared with the intermediate and low densities at both sowing dates. The developed hybrid G36 exhibited the highest agronomic performance under high planting density at timely and late sowing. Additionally, G38, G16, G37, G23, G5, G31, G18, G7, G2, G20, G29, and G17 displayed high agronomic traits at both sowing dates. Joint regression and AMMI analyses revealed significant genotype, agro-environment, and genotype × agro-environment interaction effects for grain yield. The AMMI biplot displayed that G39 was closest to the ideal stable hybrid, and the hybrids G36, G18, G38, G17, G2, and G37 were considered desirable stable hybrids. Moreover, the GGE biplot indicated that a high planting density at an optimal sowing date could be considered a representative environment for discriminating high-yielding maize hybrids. The designated promising hybrids are recommended for further inclusion in maize breeding due to their stability and high yields.

12.
Eur Ann Allergy Clin Immunol ; 54(5): 218-228, 2022 Sep.
Article de Anglais | MEDLINE | ID: mdl-33939346

RÉSUMÉ

Summary: Background. Patients show varied results to allergen immunotherapy (AIT. The reason for this variability is unclear. Objective. To describe the relationship between AIT efficacy and demographic characteristics, as well as pre-treatment plasma levels of specific IgE-antibodies to grass and birch pollen. Methods. A retrospective study was performed based on medical records of 128 patients who received AIT. The patients completed a questionnaire and pre-AIT plasma levels of allergen-specific IgE to grass and birch pollen were measured using EUROLINE DPA-Dx pollen 1 method. Results. Seventy percent of patients classified their allergic symptoms as less severe after AIT. Twenty-seven percent had received AIT targeting only grass pollen, 19% targeting only birch pollen, and 55% targeting both grass and birch. A total of 35 different IgE profiles were found across our study population. On comparison of the demographic characteristics and concentration of allergen-specific IgE-antibodies, no statistically significant differences could be found.Conclusions. The majority of patients rated their allergic symptoms as less severe after AIT. No clear relationship could be demonstrated between pre-treatment allergen-specific IgE concentration, or demographic characteristics, and effect of AIT. There may be other factors underlying the different responses to AIT.


Sujet(s)
Rhinite allergique saisonnière , Allergènes , Désensibilisation immunologique/méthodes , Humains , Immunoglobuline E , Poaceae , Études rétrospectives , Rhinite allergique saisonnière/diagnostic , Rhinite allergique saisonnière/thérapie
13.
J Cheminform ; 13(1): 97, 2021 Dec 11.
Article de Anglais | MEDLINE | ID: mdl-34895295

RÉSUMÉ

Chemical patents are a commonly used channel for disclosing novel compounds and reactions, and hence represent important resources for chemical and pharmaceutical research. Key chemical data in patents is often presented in tables. Both the number and the size of tables can be very large in patent documents. In addition, various types of information can be presented in tables in patents, including spectroscopic and physical data, or pharmacological use and effects of chemicals. Since images of Markush structures and merged cells are commonly used in these tables, their structure also shows substantial variation. This heterogeneity in content and structure of tables in chemical patents makes relevant information difficult to find. We therefore propose a new text mining task of automatically categorising tables in chemical patents based on their contents. Categorisation of tables based on the nature of their content can help to identify tables containing key information, improving the accessibility of information in patents that is highly relevant for new inventions. For developing and evaluating methods for the table classification task, we developed a new dataset, called CHEMTABLES, which consists of 788 chemical patent tables with labels of their content type. We introduce this data set in detail. We further establish strong baselines for the table classification task in chemical patents by applying state-of-the-art neural network models developed for natural language processing, including TabNet, ResNet and Table-BERT on CHEMTABLES. The best performing model, Table-BERT, achieves a performance of 88.66 micro-averaged [Formula: see text] score on the table classification task. The CHEMTABLES dataset is publicly available at https://doi.org/10.17632/g7tjh7tbrj.3 , subject to the CC BY NC 3.0 license. Code/models evaluated in this work are in a Github repository https://github.com/zenanz/ChemTables .

14.
Front Res Metr Anal ; 6: 654438, 2021.
Article de Anglais | MEDLINE | ID: mdl-33870071

RÉSUMÉ

Chemical patents represent a valuable source of information about new chemical compounds, which is critical to the drug discovery process. Automated information extraction over chemical patents is, however, a challenging task due to the large volume of existing patents and the complex linguistic properties of chemical patents. The Cheminformatics Elsevier Melbourne University (ChEMU) evaluation lab 2020, part of the Conference and Labs of the Evaluation Forum 2020 (CLEF2020), was introduced to support the development of advanced text mining techniques for chemical patents. The ChEMU 2020 lab proposed two fundamental information extraction tasks focusing on chemical reaction processes described in chemical patents: (1) chemical named entity recognition, requiring identification of essential chemical entities and their roles in chemical reactions, as well as reaction conditions; and (2) event extraction, which aims at identification of event steps relating the entities involved in chemical reactions. The ChEMU 2020 lab received 37 team registrations and 46 runs. Overall, the performance of submissions for these tasks exceeded our expectations, with the top systems outperforming strong baselines. We further show the methods to be robust to variations in sampling of the test data. We provide a detailed overview of the ChEMU 2020 corpus and its annotation, showing that inter-annotator agreement is very strong. We also present the methods adopted by participants, provide a detailed analysis of their performance, and carefully consider the potential impact of data leakage on interpretation of the results. The ChEMU 2020 Lab has shown the viability of automated methods to support information extraction of key information in chemical patents.

15.
Water Environ Res ; 93(9): 1476-1486, 2021 Sep.
Article de Anglais | MEDLINE | ID: mdl-33704854

RÉSUMÉ

The aim of this study is to find out a sustainable and cost-effective solution to manage hazardous shock loads from metal finishing and electro-coating industry. Results indicated that the main sources of hazardous wastewater are coming from batch chemical cleaning of degreasing basin (CCDB) (pH 13) and contains very hazardous chemicals, batch chemical cleaning of phosphating basin (CCPB) (pH 1.03) and contains high concentrations of iron (2300 mg/L) and zinc (2400 mg/L) and degreasing basin contents (DBC). Different treatment approaches were investigated. Results indicated that mixing CCDB with CCPB at their actual discharge allowed to form a self-coagulant of metal hydroxide which was utilized to treat the (DBC) followed by sedimentation. Removal efficiency of COD (87%), TSS (94%), and oil and grease (92%) were achieved. To compare the efficiency of this treatment approach, conventional chemical coagulation of DBC was carried out using FeCl3 but the amount was very high. In conclusion, results proved the advantage of using self-coagulation to treat DBC since it eliminates the use of external chemicals and provides an integrated solution for the three main sources of hazardous pollutants. PRACTITIONER POINTS: The manuscript provide an innovative and sustainable solution to the shock loads of hazardous wastewater generated from metal finishing and E-coating industry by utilizing iron-rich wastewater from chemical cleaning of phosphating basin and alkaline wastewater from chemical cleaning of degreasing basin to produce metal hydroxide. The metal hydroxide was cost-effective and technically effectively than external coagulant in treating highly polluted degreasing basin content at due discharge time. Iron-rich wastewater could be used to produce self-coagulant of iron hydroxide. Mixing iron rich wastewater and alkaline wastewater produce iron hydroxide. Iron hydroxide is cost-effective in treating hazardous wastewater of degreasing basin.


Sujet(s)
Eaux usées , Polluants chimiques de l'eau , Déchets industriels/analyse , Fer , Métaux , Élimination des déchets liquides
16.
Radiother Oncol ; 155: 254-260, 2021 02.
Article de Anglais | MEDLINE | ID: mdl-33317997

RÉSUMÉ

BACKGROUND AND PURPOSE: Stereotactic Body Radiotherapy (SBRT) has emerged as a standard treatment for inoperable early-stage non-small cell lung cancer (NSCLC) with remarkable local control. However, it is not clear if this local control translates to overall survival (OS). The objective of this study is to investigate the impact of SBRT on the OS of early-stage NSCLC patients and examine if the extent of this impact changes with the era of diagnosis, T stage, age, and comorbidity status. MATERIALS AND METHODS: Using the National Cancer Database, we compared the OS of cT1-3 cN0 cM0 NSCLC patients with SBRT or observation. Multivariable analyses were adjusted for age, race, sex, income, education, place of living, hospital type, insurance status, comorbidity score, histology types, and diagnosis year. RESULTS: Among 50,819 patients, 27,027 (53.18%) received SBRT and 23,792 (46.82%) were observed. Multivariable Cox Proportional-Hazards analysis demonstrated SBRT was associated with an improved OS compared to observation (HR:0.56, p < 0.001). Subset multivariable Cox Proportional-Hazards analyses stratified by T stage, year of diagnosis, age, or Charlson Score revealed that HRs of SBRT vs. observation decrease from cT1 to cT3 (0.73-0.68), from 2004 to 2015 (0.65-0.51), from <50 to ≥80 years old (1.04-0.58) and from a Charlson Score 0 to 2 (0.69-0.58). CONCLUSION: SBRT was associated with improved OS compared to no treatment in early-stage NSCLC. The magnitude of the impact of SBRT on OS increases in patients with advanced age, higher T stages, higher comorbidity scores and more recent treatment eras.


Sujet(s)
Carcinome pulmonaire non à petites cellules , Tumeurs du poumon , Radiochirurgie , Carcinome pulmonaire à petites cellules , Sujet âgé de 80 ans ou plus , Carcinome pulmonaire non à petites cellules/anatomopathologie , Humains , Tumeurs du poumon/anatomopathologie , Stadification tumorale , Résultat thérapeutique
17.
Heliyon ; 6(11): e05584, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-33294709

RÉSUMÉ

Hyperlipidemia has been related to sever health outcome include cardiovascular complication, metabolic disorders and infertility. Moreover, obesity has also been linked to dangerous effects on testicular morphology, spermatogenesis and sperm malformation. Many studies using different herbal medicines exert protective and therapeutic effect on the testes, spermatogenesis and fertility in animals fed high fat diet. Objective: this study aimed to find out the protective effect of cinnamon on testes of albino rat fed high fat diet (HFD). Forty adult male albino rats were selected and equally divided into 4 groups. Group 1: animals of this group were fed standard diet. Group 2: rats were fed standard diet and cinnamon "15% weight by weight, w/w" for 8 weeks. Group 3: animals in this group were fed HFD (2% cholesterol, 15 % sucrose, 15% corn, 15% cocoa butter, starch and 4.7% cellulose) for 8 weeks. Group 4: animals in this group were fed HFD and cinnamon. At the end of 4 weeks half animals were sacrificed and the rest of animals were sacrificed at the end of 8 weeks and blood samples were collected to assay the testosterone level. As well as testes were taken and prepared for both histological and ultrastructure studies. Histological examination of testicular tissue of HFD-fed animals revealed many pathological changes include degenerated seminiferous tubules, distorted germinal layers and interstitial tissue appeared degenerated with intertubular hemorrhage. Ultrastructural observations showed severe degenerated features including both different types of spermatogonia and interstitial tissue. On the other hand, both histological and ultrastructural alterations were substantially but not completely protect in obese animals fed HFD and cinnamon for 4 weeks while advanced degree of improvement tissue appeared after 8 weeks of the same treatment. As well as, significantly increase in the level of testosterone was recorded when compared with HFD-fed animals. The present work concluded that cinnamon dietary uptake may improve testicular damage induced by HFD as it has anti-inflammatory, anti-obesity and antioxidant activities.

18.
Animals (Basel) ; 10(10)2020 Oct 19.
Article de Anglais | MEDLINE | ID: mdl-33086506

RÉSUMÉ

A 45-day feeding trial was conducted to assess the capacity of juvenile Nile tilapia (2.12 ± 0.02 g) to utilize different sources of carbohydrate in their diets. Growth performance, nutrient digestibility, hematological parameters, and hepatic oxidative stress were evaluated. Four experimental diets were formulated to be isonitrogenous (25% crude protein) and isolipidic (10% crude lipid), each containing 20% glucose (GLU-diet), maltose (MAL-diet), dextrin (DEX-diet), and corn starch (CST-diet), respectively. At the end of feeding trial, survival in all groups was above 90% and was not significantly different among groups. The results indicated that fish fed the DEX-diet and CSTA-diet showed significantly (p < 0.05) better specific growth rate (SGR), feed conversion ratio (FCR), and protein efficiency ratio (PER) compared with those fed the other diets. The dry matter and carbohydrate digestibility were significantly higher (p < 0.05) in groups fed on dextrin and corn starch diets. However, the digestibility of crude protein and energy in diets did not differ significantly (p > 0.05) among groups fed on experimental diets. The activities of analyzed antioxidant enzymes in the liver were significantly (p < 0.01) higher in groups fed on glucose and maltose diets when compared to other groups. Hematological parameters were affected by the dietary carbohydrate sources; there was a significant increase in hematocrit (Ht), hemoglobin (Hb), and mean corpuscular volume (CMV) in the blood of fish fed on dextrin and cornstarch diets compared to other experimental diets. These results indicated that low complexity carbohydrate sources induced oxidative stress and depressed growth performance. Overall, these results indicate that dietary dextrin and starch were more efficiently utilized than glucose as an energy source by juvenile Nile tilapia. This information is of increasing interest in fish nutrition to provide healthy and economically feed formulations.

19.
Mar Pollut Bull ; 159: 111490, 2020 Oct.
Article de Anglais | MEDLINE | ID: mdl-32738641

RÉSUMÉ

Laboratories from 14 countries (with different levels of expertise in radionuclide measurements and 210Pb dating) participated in an interlaboratory comparison exercise (ILC) related to the application of 210Pb sediment dating technique within the framework of the IAEA Coordinated Research Project. The laboratories were provided with samples from a composite sediment core and were required to provide massic activities of several radionuclides and an age versus depth model from the obtained results, using the most suitable 210Pb dating model. Massic concentrations of Zn and Cu were also determined to be used for chronology validation. The ILC results indicated good analytical performances while the dating results didn't demonstrate the same degree of competence in part due to the different experience in dating of the participant laboratories. The ILC exercise enabled evaluation of the difficulties faced by laboratories implementing 210Pb dating methods and identified some limitations in providing reliable chronologies.


Sujet(s)
Radio-isotopes du plomb/analyse , Plomb , Surveillance de l'environnement , Sédiments géologiques , Humains , Radiométrie
20.
Heliyon ; 5(9): e02387, 2019 Sep.
Article de Anglais | MEDLINE | ID: mdl-31517117

RÉSUMÉ

Intrauterine exposure to antiepileptic drugs (AEDs) is associated with neurodevelopmental alterations causing postnatal behavioral and cognitive alterations. These disorders are associated with the interference of these AEDs with the developing cerebral cortex and hippocampal neurons. Therefore, it is crucial to identify the drugs that should be avoided during pregnancy in order to prevent AED mediated developmental alterations. The present study was conducted to investigate the effects of prenatal exposure to the antiepileptic drug gabapentin (GBP) on the rat fetal brain during the organogenesis phase and to examine the potential ameliorative effect of ginger (Zingiber officinale). Consequently, the current study addressed the developmental neural changes on the histological, immuno-histochemical and ultrastructural levels. The brain of fetuses from the GBP group showed a highly significant decrease in their weight. Histologically, the cerebral cortex and hippocampus regions of fetuses maternally injected with GBP showed layer disorganization, vacuolated neuropil and massive cell degeneration. The expression of Caspase 3 was significantly increased in the brain of GBP fetuses, unlike the expression of Bcl-2 which was significantly decreased. On the ultrastructure level, the neurons showed pyknotic and chromatolytic nuclei. The cytoplasm was rarefied with swollen organelles. Co-administration of ginger evidently ameliorated most of these effects. In conclusion, GBP administration during pregnancy could possibly affect the developing fetal brain and ginger may have ameliorating effect against the induced GBP neurotoxicity and should be taken in parallel.

SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...